Ligand validation:3VVK

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 3VVK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VVK_BNG_A_303	19%	39%	0.262	0.857	1.61	0.8	5	1	0	0	100%	1
3VVK_BNG_B_302	19%	41%	0.259	0.851	1.6	0.73	6	-	2	0	100%	1
3VVK_BNG_A_302	16%	38%	0.252	0.818	1.75	0.72	6	-	2	0	100%	1
3VVK_BNG_D_304	14%	36%	0.208	0.754	1.75	0.78	6	-	0	0	100%	1
5B0W_BNG_F_304	74%	49%	0.088	0.917	1.25	0.73	3	-	2	0	100%	1
5ETZ_BNG_B_304	58%	41%	0.143	0.921	1.6	0.7	6	-	1	0	100%	1
4QRY_BNG_E_301	43%	39%	0.171	0.894	1.69	0.7	6	-	4	0	100%	1
3QBI_BNG_B_402	24%	40%	0.216	0.843	1.68	0.7	6	-	0	0	100%	1
3QBG_BNG_B_402	17%	40%	0.295	0.876	1.65	0.71	6	-	0	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4DVE_BNG_B_202	81%	66%	0.092	0.945	0.47	0.83	-	1	0	0	100%	0.5
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
4MUU_BNG_A_202	70%	41%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66
4HHR_BNG_A_714	68%	17%	0.098	0.907	0.83	2.76	2	9	1	0	100%	0.381

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.